Similar Papers

Paper Title
Journal
Date
Author
Immunogenicity of adalimumab reference product and adalimumab-adbm in patients with rheumatoid arthritis, Crohn’s disease and chronic plaque psoriasis: a pooled analysis of the VOLTAIRE trials
Vibeke Strand ... Shaun Bender
BMJ Open | VOL. 14
Vibeke Strand, et. al.Vibeke Strand ... Shaun Bender
01 Nov 2024
Pooled safety analysis from the VOLTAIRE clinical trials of adalimumab-adbm and adalimumab reference product in patients with rheumatoid arthritis, Crohn’s disease, and chronic plaque psoriasis
Stanley Cohen ... Dottie Mccabe
Expert Opinion on Biological Therapy | VOL. ahead-of-print
Stanley Cohen, et. al.Stanley Cohen ... Dottie Mccabe
11 Nov 2024
FKB327, an adalimumab biosimilar, versus the reference product: results of a randomized, Phase III, double-blind study, and its open-label extension
Mark C Genovese ... Juan Ignacio Vargas
Arthritis Research & Therapy | VOL. 21
Mark C Genovese, et. al.Mark C Genovese ... Juan Ignacio Vargas
01 Dec 2019
Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial
Stephen Hanauer ... Stefan Schreiber
The Lancet Gastroenterology & Hepatology | VOL. 6
Stephen Hanauer, et. al.Stephen Hanauer ... Stefan Schreiber
11 Aug 2021
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Dysfunctional KLRB1+CD8+ T-cell responses are generated in chronically inflamed systemic sclerosis skin.
Alyxzandria M Gaydosik ... Patrizia Fuschiotti
Annals of the rheumatic diseases | VOL. -
Alyxzandria M Gaydosik, et. al.Alyxzandria M Gaydosik ... Patrizia Fuschiotti
01 Feb 2025
Lipidomics unravels lipid changes in osteoarthritis articular cartilage.
Qiongfei Zhou ... Rik J Lories
Annals of the rheumatic diseases | VOL. -
Qiongfei Zhou, et. al.Qiongfei Zhou ... Rik J Lories
01 Feb 2025
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database.
Qingran Yan ... Oliver Distler
Annals of the rheumatic diseases | VOL. -
Qingran Yan, et. al.Qingran Yan ... Oliver Distler
01 Feb 2025
Reduced organ damage accumulation in adult patients with SLE on anifrolumab plus standard of care compared to real-world external controls.
Zahi Touma ... Miina Waratani
Annals of the rheumatic diseases | VOL. -
Zahi Touma, et. al.Zahi Touma ... Miina Waratani
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.